According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Inside human cells, biology has pulled off the ultimate packing job, figuring out how to fit six feet of DNA into a nucleus ...

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break—when both ...

New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by ...

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication process can cause alterations in genomic DNA, promoting cellular ageing, cancer, ...